Connecticut 2022 2022 Regular Session

Connecticut House Bill HB05044 Comm Sub / Bill

Filed 03/28/2022

                     
 
LCO    \\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-R01-
HB.docx  
1 of 14 
  
General Assembly  Substitute Bill No. 5044  
February Session, 2022 
 
 
 
 
 
AN ACT IMPLEMENTING THE GOVERNOR'S BUDGET 
RECOMMENDATIONS REGARDING THE USE OF OPIOID LITIGATION 
PROCEEDS.  
Be it enacted by the Senate and House of Representatives in General 
Assembly convened:
Section 1. (NEW) (Effective July 1, 2022) As used in this section and 1 
sections 2 to 5, inclusive, of this act: 2 
(1) "Commissioner" means the Commissioner of Mental Health and 3 
Addiction Services. 4 
(2) "Committee" means the Opioid Settlement Advisory Committee 5 
established pursuant to section 3 of this act. 6 
(3) "Department" means the Department of Mental Health and 7 
Addiction Services. 8 
(4) "Evidence-based" means meeting one of the following evidentiary 9 
criteria for an activity, practice, program, service, support or strategy: 10 
(A) Meta-analyses or systematic reviews have found the activity, 11 
practice, program, service, support or strategy to be effective; (B) 12 
evidence from a scientifically rigorous experimental study, including, 13 
but not limited to, a randomized controlled trial, demonstrates the 14 
activity, practice, program, service, support or strategy is effective; or 15  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
2 of 14 
 
(C) multiple observational studies from locations in the United States 16 
indicate the activity, practice, program, service, support or strategy is 17 
effective. As used in this subdivision, "effective" means helping persons 18 
avoid the development and progression of substance use disorders or 19 
drug-related harms, reducing the adverse consequences of substance 20 
use among persons who use substances, or managing, slowing the 21 
progression of, or supporting recovery from a person's substance use 22 
disorder or co-occurring mental health disorder. 23 
(5) "Fund" means the Opioid Settlement Fund established pursuant 24 
to section 2 of this act. 25 
(6) "Harm reduction" means a reduction of, or attempt to reduce, the 26 
adverse consequences of substance use, including, but not limited to, by 27 
addressing the substance use and conditions that give rise to such 28 
substance use. "Harm reduction" includes, but is not limited to, syringe 29 
service programs, naloxone distribution and public awareness 30 
campaigns about Good Samaritan laws. 31 
(7) "Infrastructure" means the resources, including, but not limited to, 32 
personnel, buildings and equipment, required for an agency of the state, 33 
municipality, other government entity or nonprofit organization to 34 
provide substance use disorder prevention, treatment, recovery and 35 
harm reduction programs, services, supports and resources. 36 
(8) "Prevention" means efforts to avoid the development and 37 
progression of substance use disorders and drug-related harms. 38 
(9) "Recovery" means an active process of continual growth that 39 
addresses the biological, psychological, social and spiritual disturbances 40 
inherent in addiction. 41 
(10) "Substance use disorder" means a pattern of use of alcohol or 42 
other substances that meets the applicable diagnostic criteria delineated 43 
in the most recent edition of the American Psychiatric Association's 44 
Diagnostic and Statistical Manual of Mental Disorders. 45  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
3 of 14 
 
(11) "Treatment" means a service to intervene upon, care for, manage, 46 
slow progression of or support recovery from a substance use disorder 47 
or co-occurring mental health disorder. "Treatment" includes, but is not 48 
limited to, an individualized service to address a person's medical 49 
needs, including, screening for and diagnosing of substance use 50 
disorders and co-occurring mental or physical health disorders and 51 
pharmacological and nonpharmacological therapeutic interventions. 52 
Sec. 2. (NEW) (Effective July 1, 2022) (a) There is established an Opioid 53 
Settlement Fund which shall be a separate nonlapsing fund 54 
administered by the committee. 55 
(b) Any moneys intended to address opioid use, related disorders or 56 
the impact of the opioid epidemic that are received by the state from any 57 
judgment, consent decree or settlement paid by any defendant, which is 58 
finalized on or after July 1, 2021, related to the production, distribution, 59 
dispensing and other activities related to opioids shall be deposited into 60 
the fund. Moneys remaining in the fund at the end of a fiscal year shall 61 
not revert to the General Fund. 62 
(c) Notwithstanding any provision of subsection (b) of this section, if 63 
the commissioner and the Attorney General certify that the purposes of 64 
such judgment, consent decree or settlement are inconsistent with the 65 
intent of the provisions of this section and sections 3 to 5, inclusive, of 66 
this act, the commissioner and Attorney General (1) shall report in 67 
writing to the committee such certification, including any identification 68 
by the commissioner and Attorney General of an alternate fund or 69 
account and explanation of the reasons for depositing such moneys in 70 
such alternate fund or account, and (2) may deposit such moneys into 71 
such alternate fund or account. The commissioner and Attorney General 72 
shall jointly report, in accordance with the provisions of section 11-4a of 73 
the general statutes, to the joint standing committee of the General 74 
Assembly having cognizance of matters relating to public health 75 
regarding the intended use of such moneys in such alternate fund or 76 
account prior to allocating such moneys for other purposes. 77  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
4 of 14 
 
(d) Beginning on December 31, 2022, and annually thereafter, the 78 
State Treasurer shall report the following to the committee: 79 
(1) An inventory of fund investments as of the most recent fiscal year; 80 
and 81 
(2) The net income earned by the fund in the most recent fiscal year. 82 
(e) Moneys in the fund shall be spent only for the following substance 83 
use disorder abatement purposes, in accordance with the controlling 84 
judgment, consent decree or settlement, as confirmed by the Attorney 85 
General's review of such judgment, consent decree or settlement and 86 
upon the approval of the committee and the Secretary of the Office of 87 
Policy and Management: 88 
(1) State-wide, regional or community substance use disorder needs 89 
assessments to identify structural gaps and needs to inform 90 
expenditures from the fund; 91 
(2) Infrastructure required for evidence-based substance use disorder 92 
prevention, treatment, recovery or harm reduction programs, services 93 
and supports; 94 
(3) Programs, services, supports and resources for evidence-based 95 
substance use disorder prevention, treatment, recovery or harm 96 
reduction; 97 
(4) Evidence-informed substance use disorder prevention, treatment, 98 
recovery or harm reduction pilot programs or demonstration studies 99 
that are not evidence-based, but are approved by the committee as an 100 
appropriate use of moneys for a limited period of time as specified by 101 
the committee, provided the committee shall assess whether the 102 
evidence supports funding such programs or studies or whether it 103 
provides a basis for funding such programs or studies with an 104 
expectation of creating an evidence base for such programs and studies; 105 
(5) Evaluation of effectiveness and outcomes reporting for substance 106  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
5 of 14 
 
use disorder abatement infrastructure, programs, services, supports and 107 
resources for which moneys from the fund have been disbursed, 108 
including, but not limited to, impact on access to harm reduction 109 
services or treatment for substance use disorders or reduction in drug-110 
related mortality; 111 
(6) One or more publicly available data interfaces managed by the 112 
commissioner to aggregate, track and report data on (A) substance use 113 
disorders, overdoses and drug-related harms, (B) spending 114 
recommendations, plans and reports, and (C) outcomes of programs, 115 
services, supports and resources for which moneys from the fund were 116 
disbursed; 117 
(7) Expenses incurred in administering and staffing the fund and the 118 
committee, as permitted by the controlling judgment, consent decree or 119 
settlement; and 120 
(8) Expenses associated with managing, investing and disbursing 121 
moneys in the fund. 122 
(f) (1) For purposes of this section, the fund balance shall be 123 
determined by the State Treasurer as of July first, annually. 124 
(2) Unless otherwise required by court order to refund to the federal 125 
government a portion of the proceeds, moneys in the fund shall be used 126 
for prospective purposes and shall not be used to reimburse 127 
expenditures incurred prior to July 1, 2022. 128 
(3) Proceeds derived from any state settlement of claims against a 129 
defendant shall be allocated and disbursed only to those municipalities 130 
that execute an agreement to participate in such settlement and adhere 131 
to the terms of such agreement, provided the allocation or disbursement 132 
of such settlement proceeds for the benefit of persons within 133 
municipalities that do not execute an agreement to participate in such 134 
settlement or do not adhere to the terms of such agreement shall not be 135 
precluded or limited. 136  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
6 of 14 
 
(4) Governmental and private provider, nongovernmental entities 137 
shall be eligible to receive moneys from the fund for programs, services, 138 
supports and resources for prevention, treatment, recovery and harm 139 
reduction. 140 
(5) Subject to the provisions of subdivision (6) of this subsection, fund 141 
disbursements shall be made by the commissioner upon approval of the 142 
committee. The commissioner shall not make or refuse to make any 143 
disbursement allowable under this subsection without the approval of 144 
the committee. The commissioner shall adhere to the committee's 145 
decisions regarding disbursement of moneys from the fund, provided 146 
such disbursement is a permissible expenditure under this section. The 147 
commissioner's role in the distribution of moneys after the distribution 148 
has been approved by the committee and after the review and approval 149 
required under subsection (e) of this section shall be ministerial and 150 
shall not be discretionary. 151 
(6) Moneys expended from the fund for the purposes set forth in 152 
subsection (d) of this section shall be supplemental to, and shall not 153 
supplant or take the place of, any other funds, including, but not limited 154 
to, insurance benefits or local, state or federal funding, that would 155 
otherwise have been expended for such purposes. The commissioner 156 
shall not disburse moneys from the fund during any fiscal year unless 157 
the Secretary of the Office of Policy and Management transmits to the 158 
committee a letter verifying that funds appropriated and allocated in 159 
such fiscal year's budget for substance use disorder abatement 160 
infrastructure, programs, services, supports and resources for 161 
prevention, treatment, recovery and harm reduction are in an amount 162 
not less than the sum of the funds for such purposes appropriated and 163 
allocated in the previous fiscal year's budget. As used in this 164 
subdivision, "supplemental" means additional funding, consistent with 165 
the provisions of this section, for substance use disorder abatement 166 
infrastructure or a substance use disorder abatement program, service, 167 
support or resource to ensure that funding in the current fiscal year 168 
exceeds the sum of federal, state, and local funds allocated in the 169  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
7 of 14 
 
previous fiscal year for such substance use disorder abatement 170 
infrastructure, program, service, support or resource. 171 
Sec. 3. (NEW) (Effective July 1, 2022) (a) There is established an Opioid 172 
Settlement Advisory Committee to ensure (1) that proceeds received by 173 
the state pursuant to section 2 of this act are allocated and spent on 174 
substance use disorder abatement infrastructure, programs, services, 175 
supports and resources for prevention, treatment, recovery and harm 176 
reduction, and (2) robust public involvement, accountability and 177 
transparency in allocating and accounting for the moneys in the fund. 178 
(b) The committee shall consist of the following members: 179 
(1) The Secretary of the Office of Policy and Management, or the 180 
secretary's designee; 181 
(2) The Attorney General, or the Attorney General's designee; 182 
(3) The Commissioners of Children and Families, Mental Health and 183 
Addiction Services and Public Health, or said commissioners' designees, 184 
who shall serve as ex-officio members; 185 
(4) The president pro tempore of the Senate, the speaker of the House 186 
of Representatives, the majority leaders of the Senate and House of 187 
Representatives and the minority leaders of the Senate and House of 188 
Representatives, or their designees; 189 
(5) Sixteen individuals representing municipalities, who shall be 190 
appointed by the Governor; 191 
(6) The executive director of the Commission on Racial Equity in 192 
Public Health, or a representative of the commission designated by the 193 
executive director; and 194 
(7) Seven individuals appointed by the commissioner as follows: (A) 195 
Two individuals in recovery from a substance use disorder or 196 
representing an advocacy group for individuals with a substance use 197  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
8 of 14 
 
disorder; (B) a provider of community-based substance use treatment 198 
services for adults, who shall be a nonvoting member; (C) a provider of 199 
community-based substance use treatment services for adolescents, 200 
who shall be a nonvoting member; (D) an addiction medicine licensed 201 
health care professional with prescribing ability, who shall be a 202 
nonvoting member; and (E) two family members of individuals with a 203 
substance use disorder. 204 
(c) The commissioner shall be chairperson of the committee. 205 
(d) Notwithstanding any other provision of the general statutes, it 206 
shall not be a conflict of interest for a trustee, director, officer or 207 
employee of an organization, or for any person having a financial 208 
interest in such organization, to serve as a member of the committee, 209 
provided such trustee, director, officer, employee or person shall 210 
disclose such position or interest to all other members of the committee 211 
and abstain from deliberation, action and vote by the committee under 212 
this section that specifically concerns the organization of which such 213 
member is a trustee, director, officer or employee, or in which such 214 
member has a financial interest. 215 
(e) All initial appointments to the committee shall be made not later 216 
than October 1, 2022. Each member of the committee, other than the ex-217 
officio members, shall serve for a term of two years, shall serve no more 218 
than two consecutive terms and may serve until a successor is 219 
appointed, except that in the event of any vacancy, the appointing 220 
authority shall fill such vacancy for the unexpired portion of such term. 221 
Any member of the committee may be removed by the appointing 222 
authority for misfeasance, malfeasance or wilful neglect of duty. 223 
(f) The committee shall have the following duties and powers: 224 
(1) Recommend and approve policies and procedures for 225 
administration of the committee and criteria for the application, 226 
awarding and disbursement of moneys from the fund, to be used for the 227 
purposes set forth in section 2 of this act; 228  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
9 of 14 
 
(2) Recommend and approve goals, objectives, rationales for such 229 
goals and objectives, sustainability plans and performance indicators 230 
relating to: (A) Substance use disorder prevention, treatment, recovery 231 
and harm reduction efforts; (B) reducing disparities in access to 232 
prevention, treatment, recovery and harm reduction programs, services, 233 
supports and resources; and (C) improving health outcomes in 234 
traditionally underserved populations, including, but not limited to, 235 
persons who live in rural or tribal communities, are members of racial 236 
or ethnic minorities or were formerly incarcerated; and 237 
(3) Approve the allocation of moneys from the fund. 238 
(g) The department shall: 239 
(1) Employ a full-time manager of the committee and provide public 240 
health research and policy expertise, support staff, facilities, technical 241 
assistance and other resources to (A) assist the manager of the 242 
committee in planning and supporting the functions of the committee, 243 
including ensuring that proceeds received by this state pursuant to 244 
section 2 of this act are allocated and spent on substance use disorder 245 
abatement infrastructure, programs, services, supports, and resources 246 
for prevention, treatment, recovery and harm reduction, and (B) ensure 247 
robust public involvement, accountability and transparency in 248 
allocating and accounting for the moneys in the fund; 249 
(2) Utilize, where feasible, appropriations from the General Fund and 250 
existing infrastructure, programs, services, supports or other resources 251 
to address substance use disorders, overdoses and drug-related harms; 252 
(3) Prepare for review and approval by the committee of the 253 
department's goals, objectives, rationales for such goals and objectives, 254 
sustainability plans and performance indicators relating to (A) 255 
substance use disorder prevention, treatment, recovery and harm 256 
reduction efforts, and (B) reducing disparities in access to prevention, 257 
treatment, recovery and harm reduction programs, services, supports 258 
and resources; 259  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
10 of 14 
 
(4) Evaluate applications and make recommendations to the 260 
committee for the awarding of contracts and disbursements of moneys 261 
from the fund exclusively for permissible expenditures set forth in 262 
section 2 of this act; 263 
(5) Upon receipt of final approval by the committee, disburse moneys 264 
from the fund exclusively for permissible expenditures set forth in 265 
section 2 of this act; 266 
(6) Approve suspensions of allocations of moneys from the fund to 267 
recipients found by the committee or commissioner to (A) be 268 
substantially out of compliance with applicable contracts, policies, 269 
procedures, rules, regulations or state or federal law, or (B) have used 270 
such awards for a purpose other than an approved purpose, provided 271 
the committee may resume approval of such allocations once the 272 
committee has determined the recipient has adequately remedied the 273 
cause of such suspension; 274 
(7) Maintain oversight over the expenditure of moneys from the fund 275 
to ensure moneys are used exclusively for the purposes set forth in 276 
section 2 of this act; and 277 
(8) Implement and publish on the department's Internet web site 278 
policies and procedures for administration of the committee and for the 279 
application, awarding and disbursement of moneys from the fund, to be 280 
used for the purposes set forth in section 2 of this act. 281 
(h) On or before October 1 2023, and annually thereafter, recipients 282 
of moneys from the fund shall file with the committee an annual report 283 
for the prior fiscal year detailing the effectiveness of infrastructure, 284 
programs, services, supports or resources that were funded, including, 285 
but not limited to, the following: 286 
(1) A description of how the recipient used the moneys for their 287 
intended purposes; 288 
(2) The number of individuals served, delineated by race, age, gender 289  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
11 of 14 
 
and any other relevant demographic factor, which shall be reported in a 290 
deidentified manner; 291 
(3) A specific analysis of whether the infrastructure, program, service, 292 
support or resources reduced mortality or improved prevention, 293 
treatment, harm reduction or recovery outcomes; and 294 
(4) If a plan to ensure the sustainability of the infrastructure, program, 295 
service, support or resources funded exists, a summary of such plan. 296 
(i) The committee shall hold quarterly public meetings. A meeting 297 
may be called by the chairperson or by a majority of the committee's 298 
members. Members may attend meetings in person, remotely by 299 
audiovisual means or, upon approval by the chairperson, by audio-only 300 
means. For each meeting of the committee, a majority of the voting 301 
members shall constitute a quorum for the transaction of business. If 302 
there is a quorum, then all actions of the committee shall be taken by an 303 
affirmative vote of a majority of the members present at the meeting. 304 
Each voting member shall have one vote. The committee shall terminate 305 
when all moneys received pursuant to section 2 of this act have been 306 
received and disbursed unless the Attorney General certifies that 307 
additional moneys are anticipated. 308 
(j) The department shall create and maintain an Internet web site 309 
where the committee shall publish (1) meeting minutes, including, but 310 
not limited to, records of all votes to approve expenditures of moneys 311 
from the fund, (2) recipient agreements and reports required under 312 
subsection (h) of this section, (3) policies and procedures approved by 313 
the committee, and (4) the committee's annual reports. 314 
Sec. 4. (NEW) (Effective July 1, 2022) The department shall disburse 315 
moneys from the fund in a manner consistent with the limitations on 316 
uses of litigation proceeds set forth in any controlling court order. If a 317 
controlling court order permits expenditures other than or in excess of 318 
expenditures authorized under section 2 of this act, the department shall 319 
adhere to the limitations on use of moneys set forth in section 2 of this 320  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
12 of 14 
 
act. If the provisions of section 2 of this act permit expenditures other 321 
than or in excess of those authorized in a controlling court order, the 322 
department shall adhere to the limitations on use of moneys set forth in 323 
the court order. 324 
Sec. 5. (NEW) (Effective July 1, 2022) (a) Not later than January 15, 325 
2023, and annually thereafter, the committee shall report, in accordance 326 
with the provisions of section 11-4a of the general statutes, to the joint 327 
standing committees of the General Assembly having cognizance of 328 
matters relating to public health and appropriations and the budgets of 329 
state agencies, on the activities carried out by the committee pursuant 330 
to sections 2 to 4, inclusive, of this act, including, but not limited to, the 331 
following: 332 
(1) The opening and closing balance of the fund for the most recent 333 
fiscal year; 334 
(2) An accounting of all credits to, and expenditures from, the fund; 335 
(3) An inventory of fund investments as of the most recent fiscal year 336 
and the net income the fund earned for the most recent fiscal year as 337 
determined by the State Treasurer pursuant to section 2 of this act; 338 
(4) The name and a description of each recipient of moneys from the 339 
fund, and the amount awarded to such recipient; 340 
(5) A description of each award's intended use, including, but not 341 
limited to, the (A) specific program, service or resource funded, (B) 342 
population served, and (C) measures that the recipient will use to assess 343 
the impact of the award; 344 
(6) The primary criteria used to determine each recipient and its 345 
respective award amount; 346 
(7) A summary of information included in the recipient report 347 
required under subsection (h) of section 3 of this act; 348  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
13 of 14 
 
(8) All applications for an award of moneys from the fund received 349 
during the most recent fiscal year; 350 
(9) A description of any finding or concern as to whether all moneys 351 
disbursed from the fund, other than expenses authorized under section 352 
2 of this act, supplemented, and did not supplant or replace, any existing 353 
or future local, state or federal government funding; 354 
(10) The performance indicators and progress toward achieving the 355 
goals and objectives developed pursuant to section 3 of this act, 356 
including, but not limited to, metrics on improving outcomes and 357 
reducing mortality and other harms related to substance use disorders; 358 
(11) The dollar amount and the percentage of the fund balance 359 
incurred for expenses of administering and staffing the fund and the 360 
committee during the most recent fiscal year; 361 
(12) The dollar amount and the percentage of the fund balance 362 
incurred for expenses associated with managing, investing and 363 
disbursing moneys in the fund during the most recent fiscal year; and 364 
(13) An explanation of any funds certified by the commissioner and 365 
Attorney General pursuant to section 2 of this act as being inconsistent 366 
with the intent of this section and sections 2 to 4, inclusive, of this act 367 
and the account or fund where such funds were deposited. 368 
(b) The commissioner shall post the report required under subsection 369 
(a) of this section on the department's Internet web site. 370 
This act shall take effect as follows and shall amend the following 
sections: 
 
Section 1 July 1, 2022 New section 
Sec. 2 July 1, 2022 New section 
Sec. 3 July 1, 2022 New section 
Sec. 4 July 1, 2022 New section 
Sec. 5 July 1, 2022 New section 
  Substitute Bill No. 5044 
 
 
LCO    {\\PRDFS1\HCOUSERS\BARRYJN\WS\2022HB-05044-
R01-HB.docx }   
14 of 14 
 
Statement of Legislative Commissioners:   
In Section 1, Subdivs. (8) and (12) were deleted and the remaining 
subdivisions were renumbered for clarity.  
 
 
PH Joint Favorable Subst.